- Sun Pharma explores funding mix for $12 billion Organon deal The Economic Times
- Son rise at Sun: Decoding the architecture of Dilip Shanghvi’s global empire Mint
- Sun Pharma’s $11.75B Organon Buy: Speciality Drugs, Global Expansion & More Deccan Herald
- Sun Pharmaceutical Industries $12B Organon Deal Marks Innovation Shift Business Viewpoint Magazine
- A $12 billion US deal pushes Sun Pharma into big leagues Moneycontrol.com